Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrin and inflammatory exudate proteins constitute the proteinaceous components found in blood clots and inflammatory fluids. Fibrin is a structural protein formed from fibrinogen through the proteolytic action of thrombin, serving as the primary scaffold for hemostasis and tissue repair (StatPearls, 2023). Inflammatory exudate is a protein-rich fluid that escapes from the vasculature into interstitial spaces during the acute inflammatory response, often containing high concentrations of fibrinogen, globulins, and cellular debris (NCBI, 2022). The accumulation of these proteins can cause localized edema and hinder the resolution of inflammation by obstructing microcirculation. Therapeutic intervention typically involves the administration of proteolytic enzymes, such as trypsin-chymotrypsin or serratiopeptidase, which catalyze the hydrolysis of these proteins into smaller, soluble peptides (PubChem, 2024). This process helps to reduce tissue swelling, alleviate pain, and promote the clearance of inflammatory products.
Proteolytic degradation of fibrin and inflammatory proteins to reduce edema and improve microcirculation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin and inflammatory exudate proteins.